Number of the records: 1  

Overexpression of Galectin-3 in Chronic Lymphocytic Leukemia Is Associated With 17p Deletion: A Short Report

  1. TitleOverexpression of Galectin-3 in Chronic Lymphocytic Leukemia Is Associated With 17p Deletion: A Short Report
    Author Michalová Zuzana 1992    SCOPUS    RID    ORCID
    Co-authors Čoma Matúš

    Gál Peter

    Šarišský Marek

    Co-authors Kičová Miroslava Gabzdilová Juliana Dedinská Kinga Guman Tomáš Hájiková Martina Veselinyová Dominika Giertlová Mária
    Source document Anticancer Research. Vol.39 , no. 6 (2019), p. 2805-2810
    Languageeng - English
    CountryGR - Greece
    Document kindrozpis článkov z periodík (rbx)
    CitationsLARSSON, Karin - HOGLUND, Martin - LARSSON, Anders - THULIN, Mans - KARLSSON, Torbjorn. Increased levels of the cardiovascular disease risk biomarkers GDF15 and myostatin in patients with chronic lymphocytic leukemia. In GROWTH FACTORS, 2020, vol. 38, no. 3-4, pp. 189-196. ISSN 0897-7194. Dostupné na: https://doi.org/10.1080/08977194.2021.1932870.
    XU, Jing-xiao - ZHANG, Rong - HUANG, Dai-jia - TANG, Ying - PING, Li-qin - HUANG, Bi-jun - HUANG, Hui-qiang - BUSSON, Pierre - LI, Jiang. Galectin-9 Facilitates Epstein-Barr Virus Latent Infection and Lymphomagenesis in Human B Cells. In MICROBIOLOGY SPECTRUM, 2023, vol., no., pp. ISSN 2165-0497. Dostupné na: https://doi.org/10.1128/spectrum.04932-22.
    CategoryADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted)
    Category of document (from 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Type of documentčlánok
    Year2019
    Registered inWOS
    Registered inSCOPUS
    Registered inCCC
    DOI 10.21873/anticanres.13408
    article

    article

    rokCCIFIF Q (best)JCR Av Jour IF PercSJRSJR Q (best)CiteScore
    A
    rok vydaniarok metrikyIFIF Q (best)SJRSJR Q (best)
    201920181.935Q40.722Q2
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.